Sectra & contextflow partner up for Radiology Symposium in Mainz
2022-10-07

On September 28, 2022, we had the pleasure of co-hosting the Mainz Radiology Symposium. Together with our partner Sectra and Prof. Peter Mildenberger, many participants came together to discuss the latest developments in Structured Reporting and Content-Based Image Retrieval (CBIR).

Here, our Business Development Manager – DACH Mark Rawanschad presented the latest version of contextflow SEARCH Lung CT, emphasizing its deep integration with Sectra PACS.

We would like to express our sincere thanks to Sectra and Prof. Mildenberger for co-organizing the event, to Bootshaus Mainz for providing an excellent venue, and to all participants for sharing their experiences.

Read up on the full event in Radiologie Magazin here (German).

Other News

Signify Research’s take on contextflow’s partnership with RevealDx
2022-10-07

Signify Research is widely-respected in our industry for its in-depth analyses of current market trends. That’s why we’re honored to have been featured in the article titled “contextflow Reveals Its Hand“, discussing the why behind our recent partnership announcment with RevealDx.

RevealDx developed RevealAIöLung, the world’s first CADx software for the characterization of lung nodules to receive the CE Mark. The company recently completed its pivotal clinical trial which demonstrated significant improvement in both early detection of malignant nodules and reduction in false positive nodules in both screening and incidental cohorts. By integrating this patented technology into clinical routine, healthcare providers can reduce unnecessary procedures, cost and stress for patients with lung nodules.

Signify Research’s take? “contextflow’s SEARCH solution remains unique in the market today. No other vendor offers a similar value proposition. Further, a study published in the Journal of the American College of Radiology highlighted Reveal DX’s ability to help clinicians diagnose lung cancer sooner with improved specificity. By bringing these capabilities together, both vendors have created a comprehensive lung cancer solution for CT imaging that can, on paper, outcompete most of its competitors.”  

Other News

Softway Medical Group partners with contextflow to bring comprehensive AI support for lung pathologies to France
2022-10-06

October 6, 2022 – With this partnership announced in advance of JFR 2022, Softway Medical – the French leader in health information systems – augments its offer for medical imaging professionals. 

By making contextflow SEARCH Lung CT accessible from its applications, Softway Medical Group is now in a position to offer its clients a complete clinical decision support solution for interstitial lung diseases (ILD), COPD and lung cancer. This is the first time that such a solution will be offered to medical imaging professionals in France. 

For users, the benefits are significant. In a recent clinical study at the Medical University of Vienna, average report reading time decreased by 31% when an earlier version of contextflow SEARCH Lung CT was present for use.*

contextflow SEARCH Lung CT, a comprehensive solution integrated directly into the radiologist’s workflow

contextflow SEARCH Lung CT is now available on Softway Medical’s SYNAPSE PACS and will soon be fully integrated into the easIA platform. The results of the analyses of this new AI algorithm will be available to the radiologist directly in the worklist of the RIS ONE MANAGER and VENUS.

This is a pragmatic response to the challenges faced by radiologists seeking to increase their productivity and the relevance of their diagnoses for the benefit of patients. “We are very pleased with this partnership with contextflow, an inspiring company with whom we share a common vision of health information systems that should serve professionals without replacing them. Our teams are working hand in hand to integrate the solution with our applications,” says Jean-Baptiste Franceschini, Marketing and Communication Director of Softway Medical Group.

The easIA platform was designed to organize, secure and centralize exchanges between the RIS and partner AI engines.

Interested parties can meet contextflow at JFR 2022 at the innovation station at Softway Medical’s stand 1N07.

*Recent clinical study conducted at the Medical University of Vienna: researchers observed an average time saving of 31% in reading studies when using

earlier version of SEARCH Lung CT.

About Softway Medical

Committed to providing healthcare professionals with the best digital solutions, SOFTWAY MEDICAL, the French leader in healthcare software, continues to innovate in order to contribute to making France one of the standard bearers of e-health. As a host and integrator of solutions for healthcare professionals for over 25 years, SOFTWAY MEDICAL’s mission is to enable

physicians to make informed decisions and fully exploit their capabilities. Because in the field of health, nothing can replace the discernment of human intelligence; thus, SOFTWAY MEDICAL considers technology and data management as a means to increase the potential of anyone who uses it. Its innovations have only one objective, to allow each of its users to fully exploit their capacities and to make informed decisions in their daily work in the interest of the patient. This profession of faith has enabled the company to become the leading French Hospital Information Systems (HIS) publisher in France. https://www.softwaymedical.fr/

Other News

Clinical study on contextflow SEARCH Lung CT published in European Radiology shows 31% reading time savings
2022-07-04

Our first clinical study in the European Radiology Journal from the European Society of Radiology has been published! The study, in collaboration with the Medizinische Universität Wien and Universitätsklinikum AKH Wien shows reading time decreased by 31% when contextflow SEARCH Lung CT was available for use. Open access link here.

Other News

The 2022 Aunt Minnie Award Nominations have been announced…and contextflow is up for two categories!
2022-09-05

This year’s campaign includes over 200 candidates in 14 categories, ranging from Most Influential Radiology Researcher to Best Educational Mobile App. contextflow was honored to be nominated in two categories:

Best New Radiology Software (SEARCH Lung CT)

Scientific Paper of the Year (Impact of a content-based image retrieval system on the interpretation of chest CTs of patients with diffuse parenchymal lung disease. Röhrich S et al, European Radiology, July 2, 2022.)

Check out the full nominee list here!

Other News

GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada
2022-08-09

Toronto, Canada – August 9 – Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector.

The companies all focus on applying Artificial Intelligence (AI) to augment medical imaging with the potential to transform how healthcare is delivered. AI is poised to increase productivity and the efficiency of care delivery and allow healthcare systems to provide better care to more people. AI can help improve the experience of healthcare practitioners, with the goal of enabling them to spend more time in direct patient care and reducing burnout.

The selected companies were chosen as they demonstrated innovative and scalable solutions to pressing problems in the healthcare sector. “GE’s Edison Digital Health Platform is designed with specific focus on hosting applications developed by innovative third parties. It comes with a rich set of development tools to build and integrate applications. We are starting to see the use of AI in clinical practice and our goal is to accelerate this by supporting the most promising innovators and playing an active role in the Canadian health tech ecosystem.” said Paritosh Dhawale, PhD, SVP and GM, Edison Digital Health Platform at GE Healthcare. The companies in the program are:

  • 16 Bit Inc :16 Bit is a physician-founded startup that created a computer-aided detection and notification software that is intended to function as an opportunistic prescreening device for low bone mineral density using routinely acquired x-rays of the chest, spine, pelvis, knee or hand.
  • Bot Image: Bot Image is a medical device company that created a product for post-processing MRI that is using artificial intelligence (AI) to aid physicians in image interpretation by providing highly accurate prostate cancer diagnostics. The software is provided as a SaaS model or can be installed behind the client’s firewall.
  • CardioWise: CardioWise is an AI cardiac image analysis company that simplifies the diagnosis of heart disease enabling a quantitative diagnostic evaluation of the heart system using CT data. CardioWise analysis will provide caregivers with next generation algorithms and data to help physicians to make better more informed decisions about patient care.
  • contextflow : contextflow develops deep learning-based tools to enable radiologists to complete their daily workload faster and with higher quality and offers comprehensive clinical decision support for lung CT, providing quantitative and qualitative analysis of lung disease patterns and nodules related to ILD, COPD and lung cancer.
  • corelinesoft: corelinesoft specializes in AI development that provides medical image processing solutions with a mission to drive for a future where one simple scan can reveal any ailment and provide for early screening and prevention – for example utilizing AI to detect nodules that have the possibility of progressing into lung cancer.
  • US2.ai: Us2.ai is a software start-up founded in 2017 and backed by Sequoia; Singapore’s Agency for Science, Technology and Research; and IHH Healthcare that automates the fight against heart disease through AI with AI-structured reports processed automatically in under 2 minutes.

“We are honored to have this exceptional group of companies on board our first Canadian Edison accelerator. Each of our finalists are solving real problems in medical imaging and we look forward to working with them over the coming months,” said Matthew Khoory, Senior Director – Solutions and Digital Development, GE Healthcare Canada.

As such, in addition to the six startups, Circle Cardiovascular Imaging, a prominent global medical imaging company, who is already collaborating and has integrated its stroke-focused AI-based tools with GE Healthcare’s FastStroke processing platform, is leveraging the Edison Accelerator to accelerate the integration of its StrokeSENS software with the Edison Platform.

Over the next three months, the seven companies will test their solution within the Edison Digital Health Platform, which takes a vendor-agnostic approach to developing and deploying Artificial Intelligence at scale integrated within the clinical workflow. Each company will get a customized program plan and hand-picked mentors with the aim to accelerate integration and commercialization.

“Nex Cubed has a successful heritage of startup formation and acceleration for companies ranging from ideation to innovation, angel to seed, and growth to IPO. This enables us to work with companies at any stage, across the globe from the USA, Luxembourg, Singapore, Korea, Canada and beyond,” said Marlon Evans, CEO at Nex Cubed. “Through our partnership with GE Healthcare, we are able to accelerate the growth and impact of innovative digital health solutions tackling critical issues within the healthcare ecosystem.”

The program culminates with an Innovation Showcase during which all participants will present to a network of investors, potential business partners and customers, who could help take their companies to the next level. Subject to applicable regulatory authorizations, successful applications may have the opportunity to be distributed through the GE Healthcare Marketplace after culmination of relevant steps that include commercial distribution agreements. GE Healthcare Marketplace is GE Healthcare’s online store that allows customers to find and buy applications and algorithms from a range of third-party developers that can be integrated within their clinical and operational workflows to help healthcare providers improve outcomes for patients.

About GE Healthcare:

GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 48,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

About Nex Cubed:

Nex Cubed is an investor and innovation partner that empowers startups, investors, corporates, academia, and governments to bring new technologies to market, helps rising companies scale, and provides paths to liquidity – the power of three. Over the last 5 years, Nex Cubed has established itself as a leader in corporate innovation and startup acceleration, creating a global ecosystem of 3 industry-specific COEs (Frontier Tech, Digital Health, and FinTech), 81 portfolio companies, 20+ corporate partners, 100+ investment partners, 50+ strategic advisors, and over 140 mentors. To date, Nex Cubed portfolio companies have an aggregate value of over half a billion dollars and nearly 60% of the Nex Cubed portfolio is led by female or minority founders.

Other News

RevealDx and contextflow team up to improve lung cancer screening in the EU via enhanced nodule characterization
2022-08-03

RevealDx appoints contextflow as its exclusive distributor in the European Union and selected territories. The companies also announce trial installation discounts for select customers.

Chest specialists RevealDx and contextflow announced today an agreement for exclusive distribution of RevealDx’ products in the EU and other selected territories. The companies will be launching their integrated solution at the upcoming IASLC World Conference on Lung Cancer in Vienna in August. 

RevealDx developed RevealAI-Lung, the world’s first CADx software for the characterization of lung nodules to receive the CE Mark. The company recently completed its pivotal clinical trial which demonstrated significant improvement in both early detection of malignant nodules and reduction in false positive nodules in both screening and incidental cohorts.* By integrating this patented technology into clinical routine, healthcare providers can reduce unnecessary procedures, cost and stress for patients with lung nodules. *publication Fall 2022

contextflow is an industry leader in AI-based medical devices for radiologists evaluating chest CTs. Its core technology is SEARCH Lung CT, a clinical decision support system that automatically detects, quantifies and visualizes key disease patterns and lung nodules in CTs of the lungs over time, displaying relevant information directly in the radiologist’s PACS viewer. The tool is relevant for the analysis of many suspected diseases, including interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD) and lung cancer. By including RevealDx’ lung nodule characterization technology into SEARCH Lung CT, contextflow strengthens its capabilities even further in the area of lung cancer screening by providing not just quantifications but also classification of lung nodule types. 

Integrating RevealDx’ nodule characterization technology into SEARCH Lung CT was a logical next step for both sides. As Chris Wood, CEO of RevealDx says, “We are thrilled to be partnering with contextflow. They have developed the most comprehensive set of tools for reading chest CT available today. Adding RevealAI-Lung to their system makes it far and away the best solution to efficiently and accurately interpret these challenging lung cancer cases.”

Markus Holzer, CEO of contextflow continues, “The RevealAI-Lung software has been well integrated into our software, creating a seamless experience for users. We recently launched our nodule detection software and quickly realized that characterization of nodules is essential to make a significant impact on patient care. Partnering with RevealDx adds a layer of detail that we feel will become indispensable for reducing false positives and false negatives during lung cancer screening as well as in standard clinical routine.”

To schedule a virtual demo or book an appointment at IASLC, contact sales@contextflow.com. 

About RevealDx

RevealDx developed RevealAI-Lung, the world’s first CADx software for the characterization of lung nodules to receive the CE Mark. RevealAI-Lung has been validated in clinical studies that show improvement in diagnostic precision using our patented methods.  Results demonstrate the software can significantly accelerate lung cancer diagnosis and reduce unnecessary procedures. https://reveal-dx.com/

Other News

The value of AI is in its integration – 3 Pioneers from LUMC share their experiences using contextflow integrated into the Sectra PACS
2022-07-14

Sectra interviewed three thought leaders from Leiden University Medical Center (LUMC) in the Netherlands about their experiences and insights on integrating AI directly into the radiology workflow. This use case shows the importance of that integration, how it’s used in clinical practice, and how they went about choosing the right types of algorithms for the hospital. 

LUMC uses contextflow’s clinical decision support system for improved analysis of lung CTs to enhance its radiology workflow with artificial intelligence. The software, SEARCH Lung CT, has been seamlessly integrated into the Sectra PACS, enabling radiologists to quantify lung abnormalities, such as lung nodules, emphysema, effusion, consolidation, pneumothorax, and many more. The software serves to assist radiologists with both quantitative and qualitative information when evaluating patients with suspected interstitial lung diseases (ILD), chronic obstructive pulmonary disease (COPD), and lung cancer. Using this AI assistance, it may also contribute to the wellbeing of radiologists at work, thus going beyond work efficiency and quality enhancement of radiological reporting.

  • Prof. Dr. H. Lamb, Professor of Radiology, Head of the Cardio Vascular Imaging Group (CVIG), Department of Radiology
  • Dr. W. Grootjans, Technical Physician, Head of the Imaging Services Group, Department of Radiology
  • S. Romeijn, Technical Physician, clinical implementation of AI, Department of Radiology

Trends in radiology: more data, higher workloads, better PACS integrations

In recent years, data volumes in radiology have increased dramatically. “We have an ever growing number of clinical imaging requests. Exams have more slices and require a higher resolution, so there is much more imaging data to review and analyze quantitatively,” says professor H. Lamb. Dr. W. Grootjans adds: “Image quantification has become a standard task in radiology, and its importance will only continue to increase. It provides referring physicians with the necessary information to personalize patient care, improve sensitivity to detect changes over time, which ultimately aims to improve patient outcomes.”

In addition, general awareness of the potential of AI is increasing. Lamb: “Since the radiological workload continues to increase and the number of radiologists will not increase, we have a challenge. AI will help to maintain high quality of image reading with sustainable well-being of radiologists, allowing them to focus more on their role as consultant and communicator. Radiology with AI support is shifting the radiologist’s role towards a navigator of healthcare. We need to keep radiologists satisfied in their jobs and likewise offer our patients good turnaround times.” 

Numerous AI algorithms have been developed in the past few years. This brings plenty of choice, but working with AI goes beyond choosing to work with a specific tool. S. Romeijn explains: “Algorithms often perform very well, but that is only the first step. The second step is integration because you can’t do anything without this. Most of the added value of AI is in its optimal software integration, in this case the PACS, which helps us get something out of it in practice. For radiologists, the right data must be in the right place at the right time. This also stimulates radiologists’ enthusiasm.” 

Choosing to work with contextflow

Dozens of companies worldwide are developing algorithms to detect lung abnormalities. LUMC chose contextflow SEARCH Lung CT, which is now one of the first tools that LUMC has integrated into its Sectra PACS. One deciding factor was this developer’s openness to improvement. “To us, the [nature of our] collaboration is an essential factor, and with this, their openness to change. You don’t just want to buy a license. You want them to customize their product and work on projects together. We are not simply their client, but we will also have to get along well with each other,” according to Lamb. 

The functionality of contextflow stood out, as it takes a general approach to image analysis. Romeijn: “Ultimately, contextflow is more widely applicable than other algorithms focusing on specific lung abnormalities. It’s a tool for the lungs and, therefore, a lot more interesting than having eight different tools that say something about a thorax CT, with all kinds of different outputs that are difficult to combine. So the vision of contextflow is very appealing to us.” 

PACS integration of contextflow and its improvements

The LUMC team met contextflow in 2018. “In those four years, we had a lot of meetings that set direction for the future. Ultimately, it’s about being able to implement your vision into the software,” says Grootjans. The integration of contextflow into the Sectra PACS started in 2020. “At the time, we were still exploring what AI was all about. Since it was one of the first AI algorithms to be implemented, we spent approximately one year on discussing IT security and filling in the paperwork. Then COVID-19 came. [At that point,] we were in touch with both Sectra and contextflow. An important thing to note is that this degree of AI integration into the PACS was unheard of before Sectra made it possible. Sectra is also currently the only PACS that is technically capable of integrating that deeply. On top of that, contextflow is one of the very few AI vendors capable of such a deep integration.”

Because it was a pioneering collaboration, all parties had to gain more insight, which then had to guide the workflow setup in the best possible way. Romeijn: “We catch up with contextflow every month. During the integration, this was daily or weekly via email to discuss the necessary tweaks and adjustments. They respond very quickly and take home our feedback.”

Formally established collaboration contracts define what the LUMC team provides and what contextflow will offer in return. “You could call these co-creation contracts,” Lamb explains. “We help them annotate lung abnormalities, and they create tailored solutions. You can’t do this from the start. First, you have to get to know and trust each other. Nowadays, we are at that stage where we can basically [try anything].” LUMC’s image annotations help validate the algorithms. In addition, the LUMC team can share their practical experience, from which contextflow learns what works well and what does not. This input will further determine the workflow and how the radiologist can interact with it.

At LUMC, the arrival of COVID-19 accelerated their pioneering with AI. Lamb: “Everyone had to work from home. Suddenly, we could start doing things we wanted to do for years. There was also a huge need for the quantification of lung patterns. What percentage of the lung was affected by COVID-19?” Many IT problems were solved during this period, including legislation-related ones.  

The integration of contextflow SEARCH Lung CT was a step-by-step process. Romeijn: “At first, we had to open a link in our PACS, directing us to a separate contextflow viewer. That was a nice integration by itself.” But the wish of the end users remained to have as much integration with the Sectra PACS as possible.   

Another improvement in the contextflow – Sectra integration is how its output can be transferred to reports. Lamb: “I [previously] couldn’t transfer the results from the analysis directly into my report. No software had this possibility. So we all asked for that.” Now it’s more a matter of checking and accepting the output before it is added to a report. This also prevents errors.

The application itself is also constantly improving. “We know that they thought carefully about longitudinal analyses. This feature has not yet been implemented, but it’s coming after this summer,” Romeijn explains. From then on, contextflow can also be used to properly visualize and quantify the development of lung abnormalities over time. Lamb: “This is what we told them from the beginning. We need to follow lung nodules over time, visualize them using graphs, doubling times, and more. They have developed this feature exactly as we want it in daily use. This development is truly a win-win. Collaboration offers you the best solutions.” According to Romeijn, it can be a challenge to test what works best in clinical practice. For example; how to choose which previous scans and series should be compared with the latest scan.

The impact of working with AI

What impact does working with AI have on radiologists? Lamb says this is difficult to say, “because how do you measure this impact?” In the Radiology AI Lab, he and his team are developing a method to quantify how focused radiologists stay in their tasks. “As radiologists, we take very few breaks. We sometimes start at 8 AM and go home at 8 PM, which shouldn’t be possible. We want to discover the parameters that are most informative about your reliability, efficiency, but above all, your job satisfaction.” This shows that working with tools like contextflow goes far beyond saving time and improving quality of care, but also about job satisfaction and preventing burnout.

Patient communication remains essential when working with AI. “They have access to their EHR (Electronic Health Record) data, but the wording is often very technical and medical. People can start panicking. We want to take that into account by having a simple patient explanation in the future,” Lamb says. Romeijn adds that if there is a difference between the AI output and what the radiologist sees, the radiologist should let the patient know why the difference exists and what findings prevail. 

At LUMC, referring clinicians have rapidly become used to the radiological output with the help of AI. Lamb explains that they see the luxury of it. “Even though it has taken some time to set up, it is a very efficient, quantitative way of communicating.” According to Grootjans, it is “vital to further involve the referring clinicians so that you keep looking at the workflow holistically. What information are you providing, and what is necessary?” Of course, the human factor will always be needed. Lamb: “I am not worried about that at all. I hope that everything will be automated at some point and that radiologists will translate this into clinical practice. They will become [more like] imaging consultants and can guide patients toward their next steps.”

Getting started with AI

As pioneers in applying AI in medical imaging, Lamb, Grootjans, and Romeijn continuously look ahead. First, portfolio management is important for every hospital. “Every hospital has a different [medical] portfolio. This portfolio selection informs the choice of algorithms you want to work with as a hospital,” says Grootjans.

Lamb recommends hospitals that start with AI to “make sure you integrate your radiology workflow in your PACS from the beginning. This helps you stay close to the images and data. The more technical aspects are complex, so you should maintain an excellent collaboration with your IT department.” 

He also emphasizes the importance of intermediaries with a background in technical medicine. In this way, the IT department better understands what the radiologists exactly need. For the LUMC, having technical physicians available to bridge implementation gap accelerated the adoption of AI in clinical practice.”

Other News

Chest experts Oxipit and contextflow team up for diagnostic quality assurance
2022-07-13

The new partnership aims to mitigate the risk associated with missed findings in CT medical imaging studies. The collaboration will combine Oxipit’s ChestEye Quality and contextflow’s SEARCH Lung CT products to identify missed findings in CT scans in near-real time. ECR 2022 will offer the first preview of the combined solution, and the first installation will be deployed at Leiden University Medical Center. 

ChestEye Quality analyzes medical images and corresponding radiologist reports. Acting as a virtual safety net, the software sends a notification to the radiologist if it detects a mismatch or a missed finding not identified in the radiologist report. 

ChestEye Quality can operate in retrospective and prospective settings, providing quality audit notifications in near-real time. The product is already deployed in more than 10 medical institutions worldwide. 

Out of nearly 200,000 analyzed chest X-ray images, an average of 1 in 552 (0.18%) chest X-ray studies feature clinically-significant missed findings. The result varies from 0.08% to 0.92% depending on the type of medical institution. 78% of the missed findings relate to pulmonary nodules, aiding earlier detection of lung cancer and significantly improving patient treatment prognosis.

The contextflow partnership will expand ChestEye Quality capabilities into the CT modality.

contextflow SEARCH Lung CT is a clinical decision support system that automatically detects, quantifies and visualizes key disease patterns and lung nodules in CTs of the lungs over time, displaying relevant information directly in the radiologist’s PACS viewer. The tool is relevant for the analysis of many suspected diseases, including interstitial lung disease (ILD), chronic pulmonary obstructive disease (COPD), and lung cancer.

In a clinical impact study at the Medical University of Vienna (MUW), an earlier version of SEARCH Lung CT showed an average reading time savings of 31% when contextflow SEARCH Lung CT is available for use with a trend towards improved diagnostic accuracy. The study was recently published in European Radiology.

“We are excited to partner with experts in CT AI medical imaging. The ChestEye Quality AI double reading approach has already proven itself in the CXR modality, helping radiologists to spot more clinically-relevant nodules and improving early diagnostics of lung cancer. Collaboration with contextflow highlights the robustness of the ChestEye Quality framework, showcasing how the AI double reader approach can be easily expanded into other medical imaging modalities,” says Oxipit CEO Gediminas Peksys.

contextflow Chief Commercial Officer Marcel Wassink continues: “Radiologists tell me they are often extremely busy or even exhausted towards the end of their shift. Reading lung CTs is a complicated task, whereby even the most experienced radiologists have only moderate consensus. Therefore they can’t deny they may sometimes oversee early signs of a disease in the scan or oversee or misjudge relevant patterns, which is supported by scientific publications. With this cooperation we aim to provide radiologists a safety net that catches potential mismatches between the contents in the radiology report and the visual findings related to all patterns in the CT scan detected by contextflow. The goal is to further support radiologists with a friendly warning system that helps them double check their analysis of the CT scan.”

The first ChestEye CT Quality deployment is planned at the Leiden University Medical Center (LUMC). 

“In the domain of chest X-ray and CT imaging, we have been successfully working with both Oxipit and contextflow for several years, with their applications integrated in the radiology workflow and in use in daily clinical practice. We are looking forward to having the quality functionality expanded to cover chest CT imaging with the goal of further improving the quality of care for our patients,” notes Head of Imaging Services Group at LUMC Dr Willem Grootjans. 

About Oxipit | www.oxipit.ai 

Oxipit develops AI applications for diagnostic medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative artificial intelligence breakthroughs to everyday clinical practice.

About contextflow | www.contextflow.com 

contextflow is a spin-off of the Medical University of Vienna (MUW) and European research project KHRESMOI, supported by the Technical University of Vienna (TU). Founded by a team of AI and engineering experts in July 2016, the company has received numerous awards; most recently, contextflow was named a Born Global Champion 2021 by the Austrian Chamber of Commerce. Its clinical decision support software SEARCH Lung CT is CE Marked and available for clinical use within Europe under the new MDR.

Other News

STATdx and contextflow announce partnership to provide radiologists with improved tools to tackle differential diagnoses
2022-07-05
  • – New partnership provides improved clinical decision support for radiologists evaluating lung CTs
  • – Allows radiologists to earn Continuing Medical Education (CME) credits when exploring STATdx content from within contextflow SEARCH Lung CT

Elsevier is delighted to announce a new product integration combining Elsevier’s STATdx platform with the power of AI from contextflow SEARCH Lung CT. 

The integration supports radiologists when evaluating complex cases, saving time, increasing confidence and fostering ongoing learning for radiologists by allowing an automatic accumulation of CME credits. 

Elsevier’s STATdx platform enables users to gain expert diagnostic support, increasing speed, accuracy and confidence when reporting on a wide range of imaging. The contextflow SEARCH Lung CT system provides objective, qualitative and quantitative information for interstitial lung disease, chronic obstructive pulmonary disease (COPD) and lung cancer cases directly within the picture archiving and communications system (PACS). The integration of the two provides radiologists with the opportunity to expand their diagnostic support.

Dr. Kotter, contextflow advisor and Consultant in Diagnostic and Interventional Radiology, University of Freiburg – Medical Center outlined the benefits of the integration for radiologists, “Reporting differential diagnoses is a key task for radiologists. The combination of STATdx trusted content integrated into contextflow SEARCH Lung CT means that the radiologist has access to the best qualitative and quantitative information at their fingertips to report on complex cases. We have trialled this solution in our clinic, and we are very much looking forward to having this integration in place to support our daily clinical work.”  

Tim Morris, VP, GTM, EMEALAAP at Elsevier continued, “We are delighted to announce this new integration with contextflow, which provides radiologists with crucial support in their diagnoses. The combination of day-to-day clinical functionality whilst also fostering ongoing learning is an incredibly powerful tool for radiologists.”            

Marcel Wassink, Chief Commercial Officer at contextflow commented, “We are excited with this integration. Providing relevant differential diagnosis literature from STATdx directly to radiologists using contextflow will help them report chest CT cases faster and with more ease, whilst also accumulating CME credits.”

About Elsevier 

Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, Scival, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitised journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Other News